Long-term follow-up after tight control of blood pressure in type 2 diabetes

Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Neil, H. Andrew W., Matthews, David R.·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0806359

Cited by (761)

Items 501–600 of 761

  1. Reduction of Recurrent Severe Hypoglycemia and Hypoglycemia Unawareness in Type 2 Diabetes by Treatment Modification and Diabetes Education
    José G. Jiménez-Montero, María L. Carvajal Solórzano, Mayra Villegas Barakat · 2020 · Diabetes & its Complications
  2. Équilibre glycémique et morbimortalité cardiovasculaire : apport des études 2008
    Christine Cugnet‐Anceau, Bernard Bauduceau · 2009 · Annales d Endocrinologie
  3. Evidence-based approach for managing hypertension in type 2 diabetes
    Robert Gabbay · 2010 · Integrated Blood Pressure Control
  4. Is there any memory effect of blood pressure lowering in diabetes?
    Francesco Paneni, Francesco Cosentino, Jasmine Passerini, Massimo Volpe · 2011 · International Journal of Cardiology
  5. Regulation of Glucose Control in People with Type 2 Diabetes: A Review and Consensus
    Jeong‐Taek Woo, Kyong Soo Park, Dong Won Byun, Kyung Soo Ko, Yoon‐Sok Chung, Doo Man Kim, Tae Sun Park, Bong Soo, In Kyu Lee, Joong Yeol Park et al. · 2010 · Korean Diabetes Journal
  6. The elusive type 2 diabetes individual achieving tight blood pressure target: A phenotypic study
    Michel Paul Hermans, Kuassi Daniel Amoussou-Guenou, Sylvie A. Ahn, Michel F. Rousseau, Ludwig Everaert, Ann Aerts · 2010 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  7. Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
    Christiaan J. Vrints, David Wood, José Luis Zamorano, Faiez M. Zannad, Şehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Shah B J Ebrahim, Giuseppe Germanò, Richard F. Hobbs et al. · 2013
  8. Diabète et hypertension artérielle
    C. Draunet-Busson, S. Laboureau-Soares Barbosa, Patrice Rodien, F. Illouz, V. Rohmer, Béatrice Bouhanick · 2010 · EMC - Endocrinologie - Nutrition
  9. Long‐term survival following the development of heart failure in an elderly hypertensive population
    Berhe Weldearegawi Sahle, Alice J. Owen, Lindon M H Wing, Lawrence Joseph Beilin, Henry Krum, Christopher Michael Reid · 2017 · Cardiovascular Therapeutics
  10. Observational analyses from ADVANCE and ADVANCE‐ON
    John Philip Chalmers, Mark Woodward · 2019 · Diabetes Obesity and Metabolism
  11. Effects of exercise training combined with psychological intervention compared to exercise training alone in prediabetes subjects
    Yu Siyu, Hong Liu, Qun Yan, Qiu Hua, Kang Wu, Ding Yibiao, Wang Wenping, She Qian, Feng Bo, Ruan Xiaonan · 2020 · Journal of Public Health
  12. Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review
    Asim Ahmed Elnour, Noora Alhajri, Israa Yousif Khidir, Abdulla Al Amoodi, Sahar Asim Ahmed, Adel Shaban Sadeq · 2020 · Current Diabetes Reviews
  13. Risk Factors and Prevention
    Larry B. Goldstein, Sudha S. Seshadri, Ralph L. Sacco · 2021 · Elsevier eBooks
  14. Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates
    Samiul A Mostafa, Ruth L. Coleman, Olorunsola F. Agbaje, Alastair McIntosh Gray, Rury R. Holman, Mary Angelyn Bethel · 2018 · Journal of Diabetes and its Complications
  15. Hypertension Treatment in Diabetes
    Hannah F. Bensimhon, Matthew Aaron Cavender · 2019 · Heart Failure Clinics
  16. The Pathogenesis of Macrovascular Complications Including Atherosclerosis in Diabetes
    Riccardo Candido, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm · 2010 · Wiley eBooks
  17. Diabetic retinopathy and other ocular complications
    Gavin Siew Wei Tan, Tien Yin Wong · 2015 · Wiley eBooks
  18. Clinical features and treatment of coronary heart disease in diabetes
    Eberhard Standl, Michael Erbach, Markolf Hanefeld E, Oliver Schnell, Bernd Stratmann, Diethelm Tschoepe · 2015 · Wiley eBooks
  19. Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors
    Peter W.F. Wilson, DAVID R. GAGNON · 2017 · Circulation
  20. Diabetic retinopathy in pregnancy: A growing problem
    Felicia Widyaputri, Lyndell L. Lim · 2023 · Clinical and Experimental Ophthalmology
  21. Diabetic Nephropathy
    Peter R Rossing, Allan Flyvbjerg · 2024 · Wiley eBooks
  22. Exploring the relationship between atenolol use and depression: A network pharmacology approach using NHANES data
    Yuhan Cao, Ziqi Wang, Yan Li · 2025 · Journal of Affective Disorders
  23. Evidence-based blood tests for monitoring adults with hypertension in primary care: rapid review, routine data analyses, and consensus study
    Martha Maria Christine Elwenspoek, Rachel O’Donnell, Catalina Lopez Manzano, Sarah Dawson, Lewis Buss, Katie Charlwood, Christina Stokes, Francesco Palma, Alastair D Hay, Penny F. Whiting et al. · 2026 · British Journal of General Practice
  24. Concomitant Hypertension and Diabetes: Role of Aortic Stiffness and Glycemic Management
    Michel E. Safar, Gérard Slama, Jacques Blacher · 2017 · American Journal of Hypertension
  25. Diabetes
    Colin Mark Dayan, Julia K. Platts · 2020
  26. Diabetic nephropathy
    Janaka J. Karalliedde, Giancarlo Janaka · 2011
  27. Hypertension and Chronic Kidney Disease Including Dialysis
    Omar Al Dhaybi, George L. Bakris · 2023 · Elsevier eBooks
  28. Integration of Diabetes Mellitus and Hypertension on Major Cardiovascular Events: An Experience From a 15-year Follow-up Cohort Study in EMR
    Masoumeh Sadeghi, Zahra Teimouri-Jervekani, Hamidreza Roohafza, Mohammad Talaei, Mohammad Hossein Paknahad, Minoo Dianatkhah, Mansoureh Boshtam, Nizal Sarrafzadegan · 2024 · Current Diabetes Reviews
  29. Yinling Qushi Granule as a therapeutic agent for metabolic syndrome: pharmacological, molecular targets, and pharmacokinetic insights
    Linlin Jin, Shaoqin Lin, He Yan, Peibo Li, Xinyan Chen, Weiwei Su, Fei Tan, Chunxiang He, Zhimin Yang, Hao Wu · 2025 · Advanced Biotechnology
  30. Epidemiology, Risk Factors, and Pathophysiology of Diabetic Retinopathy
    Neelakshi Bhagat, Marco A. Zarbin · 2014 · Springer eBooks
  31. 14. Treat to Target Strategy in Rheumatoid Arthritis
    Tsutomu Takeuchi, Yuko Kaneko · 2014 · Nihon Naika Gakkai Zasshi
  32. Prevention of Cardiovascular Disease in Older Adults
    Jerome L. Fleg, NANETTE KASS WENGER · 2014 · Springer eBooks
  33. Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus
    Pasquale J Palumbo, Jonathan Wert · 2010 · Vascular Health and Risk Management
  34. Innovations thérapeutiques dans la rétinopathie diabétique
    Pascale Massin · 2011 · Journal Français d Ophtalmologie
  35. Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetes
    Jun-Long Zhang, Xin-hua Xiao, L. Ji · 2013 · Wuhan University Journal of Natural Sciences
  36. Management of hypertension in diabetic patients: outstanding issues
    Miguel Camafort, Vivencio Barrios, António Coca · 2011 · Expert Review of Cardiovascular Therapy
  37. Type 2 diabetes: the evolution of a disease
    Harold E. Lebovitz · 2012 · The British Journal of Diabetes
  38. Intensive Glucose Control and Cardiovascular Outcomes: Focused on Recent Clinical Trials
    Woo Je Lee, Kyung Soo Ko, Byoung Doo Rhee · 2008 · Journal of Korean Endocrine Society
  39. Using data to inform care needs planning for people with diabetes
    Naomi Holman, Anne Phillips · 2011 · Practice Nursing
  40. Management of Chronic Kidney Disease in Older Adults
    Jocelyn E. Wiggins, Sanjeevkumar R. Patel · 2010 · Aging Health
  41. Encuesta Nacional del Tratamiento y Control Metabólico y de los Factores de Riesgo Cardiovascular de los pacientes con diabetes mellitus tipo 2, atendidos por especialistas en Medicina Interna
    Jorge Escobedo, Joaquín Reinoso Reyes, Lucía Flores Gómez, Leonardo Olvera Gracida, Pablo Heredia Melgar, Jaime Carranza Madrigal, José Luis Aguilar Guerra, Luz Odette Villegas Pichardo, José Antonio Vidales Rosales, Anaid Ruiz Landaverde et al. · 2010 · Medicina Interna de México
  42. The impact of early intensive glucose control for prophylaxis of complications of type 2 diabetes mellitus (results of UKPDS study and 10-year follow-up study)
    Е. А. Ушкалова, Гущина Юлия Шамилевна, Е. А. Ушкалова, Yu Sh Guschina · 2009 · Obesity and metabolism
  43. BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
    Леонова Марина Васильевна · 2012 · Rational Pharmacotherapy in Cardiology
  44. Europejskie wytyczne dotyczace zapobiegania chorobom serca i naczyń w praktyce klinicznej na 2012 rok
    Joep Perk, Guy De Backer, H. Gohlke, Ian M Graham, Željko Reiner, W. M. Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cífková et al. · 2012 · Ghent University Academic Bibliography (Ghent University)
  45. An intriguing association between congestive heart failure and diabetes mellitus
    Wei-Feng Shen · 2010 · Chinese Medical Journal
  46. Preventing a First Stroke
    Larry B. Goldstein, Ralph L. Sacco · 2015 · Elsevier eBooks
  47. Une étude scandinave propose de démembrer les deux grands types de diabète de l’adulte en cinq catégories : même les Scandinaves peuvent perdre le Nord !
    Louis Monnier, C Colette · 2018 · Médecine des Maladies Métaboliques
  48. Cardiovascular Risk Factors
    2023 · Toxicology and Applied Pharmacology Insights
  49. Vascular risk factors for optical coherence tomography‐detected macular cysts: The Maastricht Study
    Eline Elodie Barbara De Clerck, Jan Schouten, Tos T. J. M. Berendschot, Fleur Goezinne, Ilona Liesenborghs, Pieter C. Dagnelie, Nicolaas C. Schaper, Abraham A. Kroon, Ronald M.A. Henry, Koen D. Reesink et al. · 2020 · Acta Ophthalmologica
  50. Innovative biodegradable dibutyrylchitin dressing for the treatment of ulcers occurring during chronic venous insufficiency in patients with type 2 diabetes
    Ewa Bieniek, Karolina Skołucka-Szary, J Brzeziński, Sylwester Piaskowski, Andrzej Lewiñski · 2021 · International Journal of Occupational Medicine and Environmental Health
  51. Control of cardiovascular risk in patients with diabetes
    Yu. V. Zhernakova, Irina Evgen'evna Chazova · 2016 · Systemic Hypertension
  52. Conquering diabetes therapeutic inertia: practical tips for primary care
    Joy Moverley, Lucia M. Novak, Jay H. Shubrook · 2022 · Journal of Osteopathic Medicine
  53. Benefits of intensified reductions in blood glucose and in blood pressure for patients with type 2 diabetes
    Nelson Wang, Sophia Zoungas, John Philip Chalmers · 2022 · La Presse Médicale
  54. Diabetic Retinopathy
    Andrea Grosso · 2023 · Updates in hypertension and cardiovascular protection
  55. Successful recommissioning of community diabetes services in West Hampshire
    Kate Fayers, Hermione Clare Price · 2015 · The British Journal of Diabetes
  56. Emerging corticosteroid delivery platforms for treatment of diabetic macular edema
    Janika Shah, Anagha Vaze, T Say, Mark C. Gillies, Samantha Fraser‐Bell · 2020 · Expert Opinion on Emerging Drugs
  57. Vascular effects following intensification of glycemic control in poorly controlled patients with long-standing type 2 diabetes mellitus
    Sofia Antoniou, Katerina Κ. Naka, Aris Bechlioulis, Marios Papadakis, Agathocles A. Tsatsoulis, Lampros K. Michalis, Stelios K. Tigas · 2021 · HORMONES
  58. La infermeria d'atenció primària en l'atenció als problemes del peu en la diabetis tipus 2 a Catalunya
    Jeroni Jurado · 2009 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  59. Glycaemic control: evaluation of HbA1c as a risk factor and the effect of modern insulins in clinical practice
    Marcus Lind · 2009 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  60. Don't blockers still have a role in hypertension?
    John Malcolm Cruickshank · 2011 · BMJ
  61. Lower Blood Pressure Goals in High-Risk Cardiovascular Patients: Are They Defensible?
    Keith A. Hopkins, George L. Bakris · 2010 · Cardiology Clinics
  62. Rosiglitazone and Cardiovascular Outcomes
    Hertzel C. Gerstein · 2013 · Circulation
  63. Cardiovascular Risk Factors: Hypertension
    Peter M. Nilsson · 2016
  64. Pathogenesis of Macrovascular Complications in Diabetes
    Stephen P. Gray, Elyse Di Marco, Riccardo Candido, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm · 2016 · Wiley eBooks
  65. Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries
    Konstantin Tachkov, Francisco Javier Somolinos-Simón, José Antonio Rivera Tapia, M. Elena Hernando, Gema García-Sáez, Maria Jordanova Dimitrova, Maria Kamusheva, Zornitsa Emilova Mitkova, Zsuzsanna Ida Petykó, Bertalan Németh et al. · 2024 · Biotechnology & Biotechnological Equipment
  66. The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture
    Rury R. Holman · 2025 · Diabetes
  67. Glycated hemoglobin and cardiovascular risk in diabetes mellitus: Evolving evidence beyond glycemic control
    Manjeet Kumar Goyal, Juniali Hatwal, Rupak Desai, Tanisha Sehgal, Akash Batta · 2026 · World Journal of Diabetes
  68. Antihypertensive Therapy Benefits: Pleiotropic Versus Blood Pressure-Dependent Mechanisms
    Sverre Erik Kjeldsen, Gordon T. McInnes · 2012 · Springer eBooks
  69. Diabetes Control and Cardiovascular Risk, Part II: Intensive Glucose Control – UKPDS Follow‐Up
    Philip R. Liebson · 2009 · Preventive Cardiology
  70. Trends in hypertension treatment in diabetes
    Keith C. Ferdinand, Daphne P. Ferdinand · 2009 · Current Hypertension Reports
  71. Het Diabetes Zorg Protocol
    Frits G.W. Cleveringa, Kees J. Gorter, Maureen van den Donk, Guy E.H.M. Rutten · 2011 · Huisarts en Wetenschap
  72. Hypertension artérielle chez le sujet diabétique
    S. Laboureau-Soares Barbosa, Patrice Rodien, C. Draunet-Busson, F. Illouz, V. Rohmer, Béatrice Bouhanick · 2011 · EMC - Cardiologie
  73. Legacy effects of RAS blockade in diabetes mellitus
    Christos Chatzikyrkou, Jan Menne · 2013 · Nature Reviews Nephrology
  74. The UK Prospective Diabetes Study (UKPDS): Its legacy for type 2 diabetes management
    Ian W Campbell · 2009 · Primary Care Cardiovascular Journal (PCCJ)
  75. Long-Term Survival after CABG in Diabetics with Aggressive Risk Factor Management
    Kendal M. Endicott, Conor F. Hynes, Dominic A. Emerson, Peter F Kokkinos, Michael David Greenberg, Gregory D. Trachiotis · 2014 · World Journal of Cardiovascular Surgery
  76. Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial
    Rohina Joshi, Bastiaan E. de Galan, John Philip Chalmers, Vlado Perkovic, Anushka A Patel · 2009 · Expert Review of Endocrinology & Metabolism
  77. Hypertension artérielle et diabète : nouvelles données apportées par l’étude ACCORD-Blood Pressure (ACCORD-BP)
    Béatrice Bouhanick, F. Ah-Kang, B Chamontin · 2011 · Médecine des Maladies Métaboliques
  78. Reflections on the 50th annual meeting of the EASD
    Mike Gwilt · 2014 · The British Journal of Diabetes
  79. Diagnosis of diabetes mellitus and pre-diabetes with fasting plasma glucose, oral glucose tolerance test and A1C level: A1C based screening may be a better diagnostic tool for diabetes mellitus
    Mehmet Ozgur Niflioglu, Mithat Bahçeci, Sakine Aslan, J.S. Shawcross, Ece Harman, Aliye Pelin Tütüncüoğlu · 2012 · Medicine Science | International Medical Journal
  80. Diagnostic et traitement de la rétinopathie diabétique
    Bénédicte Dupas, Pascale Massin · 2011 · EMC - Endocrinologie - Nutrition
  81. Primary Prevention of Stroke
    Larry B. Goldstein, Ralph L. Sacco · 2011 · Elsevier eBooks
  82. Diabetes in the Young
    Giuseppina Imperatore, Barbara L. Linder, David J. Pettitt · 2010 · Oxford University Press eBooks
  83. 33 – Hypertension and Chronic Kidney Disease
    Hillel K. Sternlicht, G. Bakris · 2018 · Elsevier eBooks
  84. Efficacy and Safety of Short Term Usage of Insulin Co - Formulation (IDegAsp) in Treatment Naive Type 2 Diabetes Mellitus Patients, Presenting with Severe Hyperglycemia and/ or Osmotic Symptoms - A Real World Observational Study
    Soumyabrata Roy Chaudhuri · 2018 · Diabetes & Obesity International Journal
  85. Beta blockers still relevant
    Jaroslav Brotánek · 2021 · Cor et Vasa
  86. Traitement de la rétinopathie diabétique
    2010 · Elsevier eBooks
  87. Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach
    Ali Abbas Rizvi · 2017 · EMJ Diabetes
  88. Stellenwert von Langzeit-Insulin-Analoga in der Therapie des Diabetes mellitus Typ 2
    Bernhard H. Ludvik, Helmut Brath, Thomas C. Wascher, Hermann Toplak · 2009 · Wiener klinische Wochenschrift
  89. Antagonistes du récepteur minéralocorticoïde
    Sophie Girerd, Matthieu Soulié, Jonatan Barrera‐Chimal, Frédéric Jaisser · 2023 · médecine/sciences
  90. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
    José Antonio Gimeno Orna, Ana Belén Mañas Martínez, Luis Rodrı́guez Padial, Manuel Anguita Sánchez, Vivencio Barrios, Javier Muñiz García, Antonio Pérez · 2024 · Endocrinología Diabetes y Nutrición (English ed )
  91. Vignette thérapeutique de l'etudiant. Quelles cibles tensionnelles viser chez un patient diabétique de type 2?
    Jean-Marie Krzesinski, André Jacques Scheen · 2012 · RMLG. Revue médicale de Liège
  92. Diabetes and the Cardiovascular System
    Paul Cohen, Jorge Plutzky · 2013 · Springer eBooks
  93. Oral Antidiyabetik İlaç Kullanan Tip 2 Diyabetes Mellitus Hastalarında Diyet ve Egzersizin Hemoglobin A1c Düzeylerine Etkisi
    Berkant Sönmez · 2015 · Konuralp Tıp Dergisi
  94. Does antihypertensive treatment have long-term benefits?
    Giuseppe Mancia · 2012 · Nature Reviews Cardiology
  95. Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction
    Siobhan H. M. Brown, Ahmed H. Abdelhafiz · 2009 · Therapy
  96. Hypertension et diabète
    R Stöckli, Lukas Zimmerli · 2009 · Forum Médical Suisse ‒ Swiss Medical Forum
  97. Endocrine Considerations in Critical Limb Ischemia
    Ioanna Eleftheriadou, Nikolaοs Tentolouris, Edward Bernard Jude · 2016 · Springer eBooks
  98. Legacy effect on mortality in antihypertensive drug comparison trials
    Costas Thomopoulos, Christina Antza · 2019 · Journal of Hypertension
  99. GLP1-Receptor Agonists in Diabetes: Drugs, General Effects, and Cardiovascular Impact
    Ikaro Soares Santos Breder, Andrei Carvalho Sposito · 2020 · Springer eBooks
  100. ADVANCE research 20 years later
    Ж. Д. Кобалава, E. L. Kolesnik · 2021 · Eurasian heart journal